Construction of a tissue microarray with two millimeters cores of endometrioid endometrial cancer: factors affecting the quality of the recipient block

References

• Camp RL, Charette LA, Rimm DL (2000)Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80: 1943–1949.
   PubMed Web of Science ®Google Scholar
• Chang E, Lee A, Lee E, Lee H, Shin O, Oh S, Kang C (2004)Her2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies. J. Korean Med. Sci. 19: 390–396.
   PubMed Web of Science ®Google Scholar
• Chen W, Foran DJ (2006)Advances in cancer tissue microarray technology: towards improved understanding and diagnostics. Anal. Chim. Acta 564: 74–81.
   PubMed Web of Science ®Google Scholar
• Cimbaluk D, Rotmensch J, Scudiere J, Gown A, Bitterman P (2007)Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets. Gynecol. Oncol. 105: 138–144.
   PubMedGoogle Scholar
• Egervari K, Szollosi Z, Nemes Z (2007)Tissue microarray technology in breast cancer HER2 diagnostics. Pathol. Res. Pract. 203: 169–177.
   PubMedGoogle Scholar
• Fergenbaum JH, Garcia-Closas M, Hewitt SM, Lissowska J, Sakoda LC, Sherman ME (2004)Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol. Biomark. Prev. 13: 667–672.
   PubMed Web of Science ®Google Scholar
• Fernebro E, Dictor M, Bendahl PO, Fernö M, Nilbert M (2002)Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch. Pathol. Lab. Med. 126: 702–705.
   PubMed Web of Science ®Google Scholar
• Fowler JM, Ramirez M, Cohn DE, Kelbick N, Pavelka J, Ben-Shachar I, Morrison C (2005)Correlation of cyclooxygenae-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am. J. Obstet. Gynecol. 192: 1262–1273.
   PubMedGoogle Scholar
• Goldman T, Drömann D, Marzouki M, Schimmel U, Debel K, Branscheid D, Zeiser T, Rupp J, Gerdes J, Zabel P, Vollmer E (2005)Tissue microarrays from HOPE-fixed specimens allow for enhanced high throughput molecular analyses in paraffin-embedded material. Pathol. Res. Pract. 201: 599–602.
   PubMedGoogle Scholar
• Gulmann C, Butler D, Kay E, Grace A, Leader M (2003)Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42: 70–76.
   PubMed Web of Science ®Google Scholar
• Gulmann C, O`Grady A (2003)Tissue microarrays: an overview. Curr. Diagn. Pathol. 9: 149–154.
   Google Scholar
• Hassan S, Ferrario C, Mamo A, Basik M (2008)Tissue microarrays: emerging standard for biomarker validation. Curr. Opin. Biotechnol. 19: 19–25.
   PubMed Web of Science ®Google Scholar
• Hernandez BY, Frierson HF, Moskaluk CA, Li YJ, Clegg L, Cote TR, McCusker ME, Hankey BF, Edwards BK, Goodman MT (2005)CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum. Pathol. 36: 275–281.
   PubMedGoogle Scholar
• Hoos A, Cordon-Cardo C (2001)Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab. Invest. 81: 1331–1338.
   PubMed Web of Science ®Google Scholar
• Huang GS, Arend RC, Li M, Gunter MJ, Chiu LG, Horwitz SB, Goldberg GL (2009)Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma. Am. J. Obstet. Gynecol. 200: 457.e1–5.
   PubMedGoogle Scholar
• Karnat AA, Younes PS, Sayeeduddin M, Wheeler TM, Simpson JL, Agoulnik AI (2004)Protein expression profiling of endometriosis: validation of 2-tissue microarrays. Fertil. Steril. 82: 1681–1683.
   PubMedGoogle Scholar
• Kim JY, Lim SJ, Park K, Lee CM, Kim J (2005)Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays. Gynecol. Oncol. 97: 337–341.
   Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998)Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4: 844–847.
   PubMed Web of Science ®Google Scholar
• Lugli A, Forster Y, Haas P, Nocito A, Bucher C, Bissig H, Mirlacher M, Storz M, Mihatsch MJ, Sauter G (2003)Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissues samples. Hum. Pathol. 34: 994–1000.
   PubMedGoogle Scholar
• Mhawech-Faucegllia P, Herrmann FR, Andrews C, South S, Beck A, Lele S, Odunsi K (2009)14-3-3ς Expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis. EJSO 35: 763–767.
   PubMedGoogle Scholar
• Mirlacher M, Simon R (2010)Recipient block in TMA technique. Methods Mol. Biol. 664: 37–44.
   PubMedGoogle Scholar
• Mucci NR, Akdas G, Manely S, Rubin MA (2000)Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum. Pathol. 31: 406–414.
   PubMed Web of Science ®Google Scholar
• Sauter G, Mirlacher M (2002)Tissue microarrays for predictive molecular pathology. J. Clin. Pathol. 55: 575–576.
   PubMed Web of Science ®Google Scholar
• Shergill IS, Shergill NK, Araya M, Patel HR (2004)Tissue microarrays: a current medical research tool. Curr. Med. Res. Opin. 20: 707–712.
   PubMed Web of Science ®Google Scholar
• Simon R, Mirlacher M, Sauter G (2004)Tissue microarrays for early target evaluation. Drug Dis. Today: Technol. 1: 41–48.
   PubMedGoogle Scholar
• Takikita M, Chung JY, Hewitt SM (2007)Tissue microarrays enabling high-throughput molecular pathology. Curr. Opin. Biotechnol. 18: 318–325.
   PubMedGoogle Scholar
• Tavassoli FA, Devilee P (2003) World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon. pp. 217–258.
   Google Scholar
• Tennstedt P, Köster P, Brüchmann A, Mirlacher M, Haese A, Steuber T, Sauter G, Huland H, Graefen M, Schlomm T, Minner S, Simon R (2012)The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers. Int. J. Oncol. 40: 261–268.
   PubMedGoogle Scholar
• Tzankov A, Went P, Zimpfer A, Dirnhofer S (2005)Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp. Gerontol. 40: 737–744.
   PubMed Web of Science ®Google Scholar
• Voduc D, Kenney C, Nielsen TO (2008)Tissue microarrays in clinical oncology. Semin. Radiat. Oncol. 18: 89–97.
   PubMed Web of Science ®Google Scholar